Fluoxétine (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fluoxétine" in French language version.

refsWebsite
Global rank French rank
2nd place
3rd place
4th place
12th place
57th place
4th place
1,735th place
168th place
1,646th place
5,917th place
low place
low place
1,248th place
778th place
low place
2,283rd place
low place
low place
low place
low place
low place
low place
9,562nd place
535th place
774th place
802nd place
low place
1,498th place
1st place
1st place
194th place
17th place
87th place
20th place
243rd place
21st place
6,302nd place
342nd place
195th place
221st place
low place
low place
234th place
147th place
149th place
80th place
222nd place
129th place

acs.org

pubs.acs.org

  • (en) « Pharma Overview », sur pubs.acs.org/cen Chemical and engineering news, (consulté le )

archive.is

cbip-vet.be

doi.org

dx.doi.org

  • David T. Wong, Jong S. Horng, Frank P. Bymaster, Kenneth L. Hauser et Bryan B. Molloy, « A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine », Life Sciences, vol. 15, no 3,‎ , p. 471–9 (PMID 4549929, DOI 10.1016/0024-3205(74)90345-2)
  • (en) Fitzgerald KT, Bronstein AC, « Selective serotonin reuptake inhibitor exposure », Top Companion Anim Med, vol. 28, no 1,‎ , p. 13-7. (PMID 23796482, DOI 10.1053/j.tcam.2013.03.003) modifier
  • (en) Langford KH, Thomas KV. « Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works » Environ Int. 2009;35(5):769. PMID 19336268 DOI 10.1016/j.envint.2009.02.007
  • (en) De Andrès F, Castañeda G, Rios A. « Use of Toxicity Assays for Enantiomeric Discrimination of Pharmaceutical Substances » Chirality 2009;21:751-758. PMID 18989896 DOI 10.1002/chir.20675
  • Enagnon Kazali Alidjinou, Famara Sané, Antoine Bertin et Delphine Caloone, « Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine », Antiviral Research, vol. 116,‎ , p. 51–54 (ISSN 1872-9096, PMID 25655448, DOI 10.1016/j.antiviral.2015.01.010, lire en ligne, consulté le )
  • Kung-Chia Young, Chyi-Huey Bai, Hui-Chen Su et Pei-Ju Tsai, « Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPARβ/γ-dependent pathways », Antiviral Research, vol. 110,‎ , p. 158–167 (ISSN 1872-9096, PMID 25151487, DOI 10.1016/j.antiviral.2014.08.002, lire en ligne, consulté le )
  • (en) Yi Xie, Pei-Pei Liu, Ya-Jun Lian et Hong-Bo Liu, « The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer’s disease and vascular dementia: focusing on fluoxetine with long follow-up periods », Signal Transduction and Targeted Therapy, vol. 4, no 1,‎ , p. 1–3 (ISSN 2059-3635, DOI 10.1038/s41392-019-0064-7, lire en ligne, consulté le )
  • (en) Keun-A Chang, Jeong a Kim, Saeromi Kim et Yuyoung Joo, « Therapeutic potentials of neural stem cells treated with fluoxetine in Alzheimer’s disease », Neurochemistry International, honoring Nobel Laureate Dr. Marshall Nirenberg on Decoding Brain Memory, vol. 61, no 6,‎ , p. 885–891 (ISSN 0197-0186, DOI 10.1016/j.neuint.2012.03.017, lire en ligne, consulté le )
  • (en) Jinping Qiao, Junhui Wang, Hongxing Wang et Yanbo Zhang, « Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model », Glia, vol. 64, no 2,‎ , p. 240–254 (ISSN 1098-1136, DOI 10.1002/glia.22926, lire en ligne, consulté le )

googleusercontent.com

webcache.googleusercontent.com

has-sante.fr

indystar.com

www2.indystar.com

  • Jeff Swiatek, « Prozac's profitable run coming to an end for Lilly », The Indianapolis Star,‎ (lire en ligne)

issn.org

portal.issn.org

  • Enagnon Kazali Alidjinou, Famara Sané, Antoine Bertin et Delphine Caloone, « Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine », Antiviral Research, vol. 116,‎ , p. 51–54 (ISSN 1872-9096, PMID 25655448, DOI 10.1016/j.antiviral.2015.01.010, lire en ligne, consulté le )
  • Kung-Chia Young, Chyi-Huey Bai, Hui-Chen Su et Pei-Ju Tsai, « Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPARβ/γ-dependent pathways », Antiviral Research, vol. 110,‎ , p. 158–167 (ISSN 1872-9096, PMID 25151487, DOI 10.1016/j.antiviral.2014.08.002, lire en ligne, consulté le )
  • (en) Yi Xie, Pei-Pei Liu, Ya-Jun Lian et Hong-Bo Liu, « The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer’s disease and vascular dementia: focusing on fluoxetine with long follow-up periods », Signal Transduction and Targeted Therapy, vol. 4, no 1,‎ , p. 1–3 (ISSN 2059-3635, DOI 10.1038/s41392-019-0064-7, lire en ligne, consulté le )
  • (en) Keun-A Chang, Jeong a Kim, Saeromi Kim et Yuyoung Joo, « Therapeutic potentials of neural stem cells treated with fluoxetine in Alzheimer’s disease », Neurochemistry International, honoring Nobel Laureate Dr. Marshall Nirenberg on Decoding Brain Memory, vol. 61, no 6,‎ , p. 885–891 (ISSN 0197-0186, DOI 10.1016/j.neuint.2012.03.017, lire en ligne, consulté le )
  • (en) Jinping Qiao, Junhui Wang, Hongxing Wang et Yanbo Zhang, « Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model », Glia, vol. 64, no 2,‎ , p. 240–254 (ISSN 1098-1136, DOI 10.1002/glia.22926, lire en ligne, consulté le )

jfponline.com

  • Sutherland JE, Sutherland SJ, Hoehns JD, « Achieving the best outcome in treatment of depression », Journal of Family Practice, vol. 52, no 3,‎ , p. 201–09 (PMID 12620174, lire en ligne)

nature.com

  • (en) Yi Xie, Pei-Pei Liu, Ya-Jun Lian et Hong-Bo Liu, « The effect of selective serotonin reuptake inhibitors on cognitive function in patients with Alzheimer’s disease and vascular dementia: focusing on fluoxetine with long follow-up periods », Signal Transduction and Targeted Therapy, vol. 4, no 1,‎ , p. 1–3 (ISSN 2059-3635, DOI 10.1038/s41392-019-0064-7, lire en ligne, consulté le )

newscientist.com

  • (en-US) « Antidepressant makes bones weaker by slowing down new growth », New Scientist,‎ 10 semptember 2016, p. 14 (lire en ligne, consulté le )

nih.gov

ncbi.nlm.nih.gov

  • David T. Wong, Jong S. Horng, Frank P. Bymaster, Kenneth L. Hauser et Bryan B. Molloy, « A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-Trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine », Life Sciences, vol. 15, no 3,‎ , p. 471–9 (PMID 4549929, DOI 10.1016/0024-3205(74)90345-2)
  • Sutherland JE, Sutherland SJ, Hoehns JD, « Achieving the best outcome in treatment of depression », Journal of Family Practice, vol. 52, no 3,‎ , p. 201–09 (PMID 12620174, lire en ligne)
  • (en) Fitzgerald KT, Bronstein AC, « Selective serotonin reuptake inhibitor exposure », Top Companion Anim Med, vol. 28, no 1,‎ , p. 13-7. (PMID 23796482, DOI 10.1053/j.tcam.2013.03.003) modifier
  • (en) Langford KH, Thomas KV. « Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works » Environ Int. 2009;35(5):769. PMID 19336268 DOI 10.1016/j.envint.2009.02.007
  • (en) Metcalfe CD, Miao XS, Koenig BG, Struger J. « Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada » Environ Toxicol Chem. 2003;22(12):2881–2889. PMID 14713027
  • (en) De Andrès F, Castañeda G, Rios A. « Use of Toxicity Assays for Enantiomeric Discrimination of Pharmaceutical Substances » Chirality 2009;21:751-758. PMID 18989896 DOI 10.1002/chir.20675
  • Enagnon Kazali Alidjinou, Famara Sané, Antoine Bertin et Delphine Caloone, « Persistent infection of human pancreatic cells with Coxsackievirus B4 is cured by fluoxetine », Antiviral Research, vol. 116,‎ , p. 51–54 (ISSN 1872-9096, PMID 25655448, DOI 10.1016/j.antiviral.2015.01.010, lire en ligne, consulté le )
  • Kung-Chia Young, Chyi-Huey Bai, Hui-Chen Su et Pei-Ju Tsai, « Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPARβ/γ-dependent pathways », Antiviral Research, vol. 110,‎ , p. 158–167 (ISSN 1872-9096, PMID 25151487, DOI 10.1016/j.antiviral.2014.08.002, lire en ligne, consulté le )

pmcpa.org.uk

  • (en) « Smithkline Beecham v Lilly -prozac advertisement », code of practice review, no 20,‎ , p. 65-68 (lire en ligne)« active medicine might remain in the body for up to 3 months (5 times the half-life)(...) "true leadership has to be earned" "reducing the risk of discontinuation syndrome" prozac is rarely associated with unpleasant antidepressant discontinuation symptoms. Prozac's long half-life may protect against such symptoms. so Prozac makes it easy for you and your patients on stopping treatment or if therapy is interrupted". »

prescrire.org

  • (rédaction), « Façonner des maladies: l'empire du marketing », Rev Prescrire., vol. 27, no 283,‎ , p. 381-382 (lire en ligne)

qmul.ac.uk

chem.qmul.ac.uk

sante.gouv.fr

agmed.sante.gouv.fr

sciencedirect.com

  • (en) Keun-A Chang, Jeong a Kim, Saeromi Kim et Yuyoung Joo, « Therapeutic potentials of neural stem cells treated with fluoxetine in Alzheimer’s disease », Neurochemistry International, honoring Nobel Laureate Dr. Marshall Nirenberg on Decoding Brain Memory, vol. 61, no 6,‎ , p. 885–891 (ISSN 0197-0186, DOI 10.1016/j.neuint.2012.03.017, lire en ligne, consulté le )

strategies.fr

web.archive.org

who.int

apps.who.int

whp-apsf.ca

  • (en) Janet C. Currie, Women and Health Protection (Organization), The Marketization of Depression: Prescribing SSRI Antidepressants to Women, Women and Health Protection, , 27 p. (ISBN 0973870109, lire en ligne)« New disorders are often used to “reposition” an SSRI as it loses market share.(...)In June 1999, when Prozac’s patent was about to expire, its manufacturer, Eli Lilly, organized a roundtable of experts in the US to get PMDD approved – in order to extend Prozac’s patent life under the name Serafem. According to Caplan, the creation of Serafem extended Lilly’s patent on Prozac by seven years, thereby adding millions of dollars in profit. 78 Although the two drugs were the same, Serafem was sold at a higher price than Prozac. »

wikipedia.org

fr.wikipedia.org

wikiwix.com

archive.wikiwix.com

wiley.com

onlinelibrary.wiley.com

  • (en) Jinping Qiao, Junhui Wang, Hongxing Wang et Yanbo Zhang, « Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model », Glia, vol. 64, no 2,‎ , p. 240–254 (ISSN 1098-1136, DOI 10.1002/glia.22926, lire en ligne, consulté le )